Phenotypic analysis of bone marrow–derived DCs
. | Untreated . | IL-10* . | LPS* . | IL-10 + LPS† . |
|---|---|---|---|---|
| Unstained | 14 | 13 | 13 | 13 |
| CD11b | 104 | 110 | 113 | 86 |
| CD11c | 63 | 79 | 70 | 64 |
| CD40 | 22 | 22 | 100 | 40 |
| CD80 | 35 | 35 | 161 | 153 |
| CD86 | 40 | 44 | 210 | 77 |
| H2K | 64 | 62 | 91 | 83 |
| IAg7 | 67 | 59 | 324 | 112 |
. | Untreated . | IL-10* . | LPS* . | IL-10 + LPS† . |
|---|---|---|---|---|
| Unstained | 14 | 13 | 13 | 13 |
| CD11b | 104 | 110 | 113 | 86 |
| CD11c | 63 | 79 | 70 | 64 |
| CD40 | 22 | 22 | 100 | 40 |
| CD80 | 35 | 35 | 161 | 153 |
| CD86 | 40 | 44 | 210 | 77 |
| H2K | 64 | 62 | 91 | 83 |
| IAg7 | 67 | 59 | 324 | 112 |